1. Tricarboxylic acid cycle dehydrogenases inhibition by naringenin: experimental and molecular modelling evidence.
- Author
-
August PM, Grings M, Grunwald MS, Zanatta G, Stone V, de Lemos Rodrigues PI, Stocher DP, Moreira JCF, Leipnitz G, and Matté C
- Subjects
- Animals, Citrate (si)-Synthase drug effects, Female, Isocitrate Dehydrogenase drug effects, Ketoglutarate Dehydrogenase Complex drug effects, Malate Dehydrogenase drug effects, Molecular Docking Simulation, Pregnancy, Rats, Rats, Wistar, Cerebellum enzymology, Citric Acid Cycle drug effects, Dietary Supplements, Flavanones administration & dosage, Maternal Nutritional Physiological Phenomena
- Abstract
The study of polyphenols' effects on health has been gaining attention lately. In addition to reacting with important enzymes, altering the cell metabolism, these substances can present either positive or negative metabolic alterations depending on their consumption levels. Naringenin, a citrus flavonoid, already presents diverse metabolic effects. The objective of this work was to evaluate the effect of maternal naringenin supplementation during pregnancy on the tricarboxylic acid cycle activity in offspring's cerebellum. Adult female Wistar rats were divided into two groups: (1) vehicle (1 ml/kg by oral administration (p.o.)) or (2) naringenin (50 mg/kg p.o.). The offspring were euthanised at 7th day of life, and the cerebellum was dissected to analyse citrate synthase, isocitrate dehydrogenase (IDH), α-ketoglutarate dehydrogenase (α-KGDH) and malate dehydrogenase (MDH) activities. Molecular docking used SwissDock web server and FORECASTER Suite, and the proposed binding pose image was created on UCSF Chimera. Data were analysed by Student's t test. Naringenin supplementation during pregnancy significantly inhibited IDH, α-KGDH and MDH activities in offspring's cerebellum. A similar reduction was observed in vitro, using purified α-KGDH and MDH, subjected to pre-incubation with naringenin. Docking simulations demonstrated that naringenin possibly interacts with dehydrogenases in the substrate and cofactor binding sites, inhibiting their function. Naringenin administration during pregnancy may affect cerebellar development and must be evaluated with caution by pregnant women and their physicians.
- Published
- 2020
- Full Text
- View/download PDF